Rockland Trust’s GSK GSK Stock Holding History

Rockland Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$874K	Sell	16,672 -11,267	-40%	-$596K	0.03%	166
2026 Q1	$1.54M	Sell	27,939 -21	-0.1%	-$1.14K	0.06%	116
2025 Q4	$1.37M	Sell	27,960 -444	-2%	-$20.7K	0.05%	129
2025 Q3	$1.23M	Buy	+28,404	New	+$1.11M	0.05%	136
2020 Q1	–	Sell	-3,470	Closed	-$204K	–	255
2019 Q4	$204K	Buy	+3,470	New	+$193K	0.02%	261

Other funds holding GSK

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Rockland Trust's GSK Position: Q2 2026 in Review

Rockland Trust reduced its GSK (GSK) stake by 40% in Q2 2026, selling an estimated $596K and leaving 16,672 shares worth $874K. The position accounts for 0.03% of the portfolio, ranked #166.

Rockland Trust first reported a position in GSK in Q4 2019 and has held it in 5 quarters since. The position peaked at $1.54M in Q1 2026. 475 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Rockland Trust held 16,672 shares of GSK worth $874K as of Q2 2026.
Rockland Trust sold 11,267 GSK shares in Q2 2026, an estimated $596K.
GSK made up 0.03% of Rockland Trust's portfolio in Q2 2026, its #166 holding.
Rockland Trust first reported a position in GSK in Q4 2019 and has held it in 5 quarters since.
Rockland Trust's GSK position peaked at $1.54M in Q1 2026.
475 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.